Advertisement
Screener

REPLIMUNE GROUP, INC. (REPL) Material Contracts

REPLIMUNE GROUP, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-06-29: Form 10-K; Exhibit 10.45; Description Form of U.K. Strategic Initiative Restricted Stock Unit Grant Agreement.
  • 2026-02-03: Form 10-Q; Exhibit 10.3; Description Third Amendment to Loan and Security Agreement, dated as of January 29, 2026, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc..
  • 2026-02-03: Form 10-Q; Exhibit 10.2; Description Form of U.K. Strategic Initiative Restricted Stock Unit Grant Agreement.
  • 2026-02-03: Form 10-Q; Exhibit 10.1; Description Form of U.K. Strategic Initiative Restricted Stock Unit Grant Agreement.
FiledFormExhibitDescription
2026-06-2910-K10.45Form of U.K. Strategic Initiative Restricted Stock Unit Grant Agreement
2026-02-0310-Q10.3Third Amendment to Loan and Security Agreement, dated as of January 29, 2026, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc.
2026-02-0310-Q10.2Form of U.K. Strategic Initiative Restricted Stock Unit Grant Agreement
2026-02-0310-Q10.1Form of U.K. Strategic Initiative Restricted Stock Unit Grant Agreement
2025-08-0710-Q10.1Amendment to Consulting Agreement, dated as of May 30, 2025, by and between Robert Coffin and Replimune, Inc.
2025-03-078-K10.1Registration Rights Agreement, dated March 5, 2025, by and among the Company and 667, L.P. and Baker Brothers Life Sciences, L.P.
2024-11-1210-Q10.3Executive Severance Plan for Chief-Level Executives
2024-11-1210-Q10.2Form of U.K. Inducement Restricted Stock Unit Grant Agreement.
2024-11-1210-Q10.1Form of U.K. Inducement Stock Option Grant Agreement.
2024-06-138-K10.2Form of Registration Rights Agreement
2024-06-138-K10.1Securities Purchase Agreement, dated June 12, 2024, by and among Replimune Group, Inc. and each of the investors as party thereto
2024-05-1610-K10.43Replimune Group, Inc. Clawback Policy
2024-05-1610-K10.42Consulting Agreement, dated as of March 31, 2024, by and between Tanya Lewis and Replimune, Inc.
2024-05-1610-K10.41Separation Agreement and Release, dated as of March 31, 2024, by and between Tanya Lewis and Replimune, Inc.
2024-05-1610-K10.40Consulting Agreement, dated as of March 26, 2024, by and between Pamela Esposito and Replimune, Inc.
2024-05-1610-K10.39Separation Agreement and Release, dated as of March 26, 2024, by and between Pamela Esposito and Replimune, Inc.
2024-05-1610-K10.36Consulting Agreement, dated as of March 25, 2024, by and between Robert Coffin and Replimune, Inc.
2024-05-1610-K10.35Separation and Transition Agreement, dated as of March 25, 2024, by and between Robert Coffin and Replimune, Inc.
2024-05-1610-K10.34Second Amended and Restated Employment Agreement, dated as of March 25, 2024, by and between Replimune, Inc. and Philip Astley-Sparke.
2024-05-1610-K10.33Second Amended and Restated Employment Agreement, dated as of March 25, 2024, by and between Replimune, Inc. and Sushil Patel.
2024-05-1610-K10.7Form of Inducement Restricted Stock Unit Grant Agreement.
2024-05-1610-K10.6Form of Inducement Stock Option Grant Agreement.
2024-05-1610-K10.5Form of Performance Stock Unit Award Agreement under 2018 Omnibus Incentive Compensation Plan and Sub-Plan for U.K. Employees.
2024-05-1610-K10.4Form of Performance Stock Unit Award Agreement under 2018 Omnibus Incentive Compensation Plan for U.S. Employees.
2024-02-0810-Q10.1Second Amendment to Loan and Security Agreement, dated as of December 22, 2023, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc.
2023-11-0710-Q10.4Amended to Employment Agreement, dated as of September 20, 2023, by and between Pamela Esposito and Replimune, Inc.
2023-11-0710-Q10.3Restricted Stock Unit Agreement, effective as of September 18, 2023, by and between Emily Hill and the Registrant.
2023-11-0710-Q10.2Stock Option Grant Agreement, effective as of September 18, 2023, by and between Emily Hill and the Registrant.
2023-11-0710-Q10.1Employment Agreement, dated as of August 31, 2023, by and between Emily Hill and Replimune, Inc.
2023-08-0310-Q10.3Consulting Agreement, dated as of May 18, 2023 by and between Jean Franchi and Replimune, Inc.
2023-08-0310-Q10.2Separation Agreement and Release, dated as of May 18, 2023 by and between Jean Franchi and Replimune, Inc.
2023-08-0310-Q10.1First Amendment to Loan and Security Agreement, dated as of June 28, 2023, by and among Replimune Group Inc., Replimune Inc., Replimune Limited and Hercules Capital, Inc.
2023-05-1810-K10.34Lease Agreement, dated as of March 23, 2023, by and among Replimune Limited, MEPC Milton Park No. 1 Limited, and MEPC Milton Park No. 2 Limited.
2023-05-1810-K10.33Restricted Stock Unit Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant.
2023-05-1810-K10.32Stock Option Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant.
2023-02-0910-Q10.4Employment Agreement, dated as of December 30, 2022, by and between Christopher Sarchi and Replimune, Inc.
2023-02-0910-Q10.3Amendment to Amended and Restated Employment Agreement, dated as of December 30, 2022, by and between Sushil Patel and Replimune, Inc.
2023-02-0910-Q10.2Employment Agreement, dated as of December 1, 2022, by and between Konstantinos Xynos and Replimune, Inc.
2022-11-0310-Q10.1Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated October 6, 2022.
2022-05-1910-K10.27Separation Agreement and Release, dated as of August 25, 2021, by and between Andrea Pirzkall and Replimune, Inc., as amended.
2022-05-1910-K10.32018 Omnibus Incentive Compensation Plan and Sub-Plan for U.K. Employees and forms of agreements thereunder.
2022-02-0310-Q10.3Lease Agreement, dated October 29, 2021, by and among Replimune Limited, MEPC Milton Park No. 1 Limited, and MEPC Milton Park No. 2 Limited.
2021-11-0410-Q10.2Amended and Restated Employment Agreement, dated as of November 2, 2021, by and between Robert Coffin and Replimune, Inc.
2021-11-0410-Q10.1Amended and Restated Employment Agreement, dated as of November 2, 2021, by and between Philip Astley-Sparke and Replimune, Inc.
2021-05-2010-K10.14Restricted Stock Unit Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant.
2021-05-2010-K10.13Stock Option Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant.
2021-05-2010-K10.12Employment Agreement, dated as of May 10, 2021, by and between Tanya Lewis and Replimune, Inc.
2021-05-2010-K10.11Amended and Restated Employment Agreement, dated as of May 3, 2021, by and between Sushil Patel and Replimune, Inc.
2021-02-0410-Q10.1Payoff Letter to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated December 15, 2020.
2020-08-0710-Q10.3Deed of Variation, dated June 29, 2020, by and among MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited, and Replimune Limited.
2020-08-0710-Q10.1Employment Agreement, dated May 25, 2020, by and between Replimune Inc. and Andrea Pirzkall.
2020-06-0310-K10.22Clinical Trial Collaboration and Supply Agreement (RP-2), dated April 12, 2019, by and between Bristol-Myers Squibb Company and Replimune, Inc.
2020-06-0310-K10.21First Amendment to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated June 1, 2020.
2020-06-0310-K10.13Separation Agreement and Release, dated as of March 30, 2020, by and between Stephen Gorgol and Replimune, Inc.
2020-02-1310-Q10.2Separation Agreement and Release, dated December 23, 2019, by and between Replimune Inc. and Howard Kaufman
2019-12-098-K10.1Employment Agreement, dated November 27, 2019
2019-08-088-K10.2Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated August 7, 2019
2019-06-2810-K10.10Employment Agreement, dated as of May 8, 2019, by and between Stephen Gorgol and Replimune, Inc.
2019-06-138-K10.1Lease, dated as of June 7, 2019, by and between Replimune Group, Inc. and ND/CR Unicorn LLC

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B